TCM

TCG Crossover Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 1,165.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+1,165.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.03B
AUM Growth
+$1.16B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$64.7M
2
+$37.1M
3
+$27.7M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$27.6M
5
SYRE icon
Spyre Therapeutics
SYRE
+$17.9M

Top Sells

1
+$49M
2
+$15.6M
3
+$14.9M
4
UPB
Upstream Bio Inc
UPB
+$10.6M
5
THRD
Third Harmonic Bio
THRD
+$10.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$604M 29.7%
7,111,596
+1,055,000
2
$148M 7.27%
3,670,206
3
$97.6M 4.8%
6,798,162
-166,213
4
$84.9M 4.17%
6,243,812
+300,000
5
$76.1M 3.74%
3,136,480
+245,664
6
$71.7M 3.53%
8,536,196
-2,199,804
7
$71.5M 3.52%
6,117,232
+798,084
8
$66M 3.25%
1,676,624
+175,000
9
$62.7M 3.09%
1,311,783
-165,810
10
$58.4M 2.87%
4,615,144
+848,484
11
$57.4M 2.82%
1,430,041
+733,038
12
$50.9M 2.5%
3,572,335
13
$48.3M 2.38%
5,250,000
14
$44.1M 2.17%
12,362,205
15
$42.2M 2.08%
1,636,275
16
$40.5M 1.99%
2,898,103
17
$39.8M 1.96%
2,117,103
-684,660
18
$38.9M 1.91%
+1,710,084
19
$30.7M 1.51%
465,257
20
$29.8M 1.46%
1,063,000
21
$28.8M 1.41%
2,452,138
22
$27.6M 1.36%
+1,745,016
23
$20.4M 1%
+436,473
24
$20.1M 0.99%
2,761,861
25
$19.9M 0.98%
+416,301
1
2